2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Deafness: new trials by email Literature Review of Deafness trials Research Report on Deafness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BF844 Safety and Pharmacokinetic Study in Healthy Volunteers BF844 - Usher Syndrome Type 3 | Phase 1 | Unknown | EyeXCel Pty. Ltd. | 76 | 2024-09-09 | 2024-09-19 |
| Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. N-Acetyl Cysteine - Ototoxic Hearing Loss | Phase 1 / Phase 2 | Unknown | Sunnybrook Health Sciences Centre | 80 | 2020-02-26 | 2023-09-06 |
Ear Diseases (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1) · Usher Syndromes (1)
Hearing Disorders (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Otorhinolaryngologic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Sensation Disorders (2) · Signs and Symptoms (2) · Abnormalities, Multiple (1) · Blindness (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Deaf-Blind Disorders (1) · Ear Diseases (1) · Eye Diseases (1)
Acetylcysteine (1)
EyeXCel Pty. Ltd. (1) · Sunnybrook Health Sciences Centre (1)
Australia (1) · Canada (1)
Benedict Tan, MBBS, FRACP (1) · Trung N Le (1)